ReviewThe Journal of clinical and aesthetic dermatology2014
Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.
Review in The Journal of clinical and aesthetic dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.Archives of dermatological research · 2021Pooled it
- Interventions for rosacea.The Cochrane database of systematic reviews · 2015Pooled it
- Ethnomedicinal plants used for immediate care in Nepal: A cross-cultural review.Journal of ethnobiology and ethnomedicine · 2025Review
- Ocular Surveillance During Off-Label Oral Isotretinoin for Photoaging: A Review of Risks and Monitoring Recommendations.Journal of cosmetic dermatology · 2025Review
- Off-Label Treatment in Inflammatory Skin Diseases-European Point of View.Journal of clinical medicine · 2025Review
- Rosacea and treatment with retinoids: a systematic review and meta-analysis.Therapeutic advances in chronic disease · 2025Review
- Practices, Efficacy, and Reported Side Effects Associated with Isotretinoin Treatment in Palestine.Patient preference and adherence · 2024Article
- A Systematic Review of Case Reports of a Rare Dermatological Condition: Elastosis Perforans Serpiginosa.Cureus · 2023Review
- [Drug therapy of acne inversa].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2018Review
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?Reviews in endocrine & metabolic disorders · 2016Review
- Isotretinoin was not associated with depression or anxiety: A twelve-week study.World journal of psychiatry · 2016Article
- Review
- Burn wound healing and treatment: review and advancements.Critical care (London, England) · 2015Review
- Adult female acne: a guide to clinical practice.Anais brasileiros de dermatologiaReview
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.Anais brasileiros de dermatologiaArticle
- Consensus on the therapeutic management of rosacea - Brazilian Society of Dermatology.Anais brasileiros de dermatologiaArticle
- Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?Clinics in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While oral isotretinoin is renowned for its ability to treat acne vulgaris, many of its off-label uses continue to go underappreciated. Since the last review on the unapproved indications of isotretinoin, relevant publications have surfaced with new recommendations. This article attempts to provide physicians with the latest information regarding successful and unsuccessful use of isotretinoin as an effective treatment for dermatological conditions, such as rosacea, psoriasis, pityriasis rubra pilaris, condyloma acuminatum, granuloma annulare, Darier's disease, systemic cutaneous lupus erythematosus, nonmelanoma skin cancer, and hidradenitis suppurativa. Variations in dosage regimens and isotretinoin viability as an alternative to other standard treatments are also discussed in relation to these conditions.
Identifiers
24765227PMC3990537What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.